• About Us
    • About Us Overview
    • Company
    • History
    • Leadership Team
    • Testimonials
    • Sponsorship
    • Anti-Bribery Statement
    • Privacy Policy
  • Products
    • Products Overview
    • Licensed Products Overview
    • Epistatus®
    • Licensed Products
      • Epistatus®
    • Unlicensed Products Overview
    • Epilepsy
    • Paediatric Medicine
    • Inborn Errors of Metabolism
    • FAQs
    • Unlicensed Products
      • Epilepsy
      • Paediatric Medicine
      • Inborn Errors of Metabolism
      • FAQs
  • Quality & Service
    • Quality & Service Overview
    • Medical Information & Quality
    • Commercial Team
    • Ordering
  • Distribution
    • Distribution Overview
    • Distribution Footprint
    • Licensing Opportunities
    • Out-licensing Opportunities
  • News & Events
  • Contact Us

Leadership Team

Chris Grimes

Chief Executive Officer

Chris Grimes is a commercial manager and has a wealth of experience within the pharmaceutical industry. Chris gained vast experience managing and launching pharmaceutical products within global markets and delivering technology transfer projects on multiple product ranges. Previously Chris has worked for UCB Pharma Ltd within their Commercial Business, becoming Business Unit Manager of the Global Minijet Franchise. Chris now provides commercial oversight and strategic guidance to support the future growth of Veriton Pharma.


 

Dr. Hannah Aiken

Chief Scientific Officer

Dr Hannah Aiken joined Veriton Pharma in 2013 as a highly skilled pharmaceutical product development expert. After completing her PhD at Kings College London, Hannah joined MedPharm where she gained extensive product development and analytical experience through the development of a variety of dosage forms. Hannah has developed projects at all stages, from proof of concept through to robust commercial products, including products which have subsequently been awarded a Marketing Authorisation. Hannah is listed as an inventor on a number of patents and has published numerous papers. At Veriton Pharma, Hannah was promoted to Head of Product Development and Medical Services in 2017 and then most recently to Chief Scientific Officer in 2018.


 

Sindy Martino

General Manager Australia and New Zealand

Sindy has extensive sales and marketing experience with leading top-performing teams and developing and launching new products.

Sindy’s previous employment experience within the pharmaceutical industry includes GlaxoSmithKline, Orphan Australia and CSL Limited.

 


 

David Hutchinson

Head of Business Development

David has an extensive understanding of the UK and European pharmaceutical environments.

David brings strong commercial and market access capabilities, driving performance of both established products and new to market product launches.

Previous experience includes Solvay Healthcare and UCB.

 

 

 

 

 

 

Bill Wild

Group Finance Director

Bill Wild is a chartered accountant with a broad range of financial and commercial skills gained firstly at TT Electronics plc, the global electronics group, and then at Greenshields JCB, one of the world’s largest construction equipment dealers. Since joining the company in 2008, he has helped develop policies and procedures that ensure sound financial management and control of the company’s business. He was promoted to Head of Finance in October 2011 and then to Group Finance Director in September 2012, a role in which he focuses on providing financial oversight and strategic guidance to support the future growth of the company.


 

Natasha Duffy

Head of Supply Chain

Solutions-orientated Supply Chain professional with a track record of successfully delivering large scale transformation and improvement projects.

Natasha holds a Lean Black Belt Certification and gained experience with Penn Pharmaceuticals, Honeywell Aerospace and Wacker Neuson.

 


 

Emeel Sefean

General Manager MEA

Emeel has 20 years of global Sales & Marketing medical and pharmaceutical experiences at senior level with strong strategic and commercial orientation with strengths in leadership, team building, business development and launching new products.

Emeel has gained his experience through working at major healthcare companies such as Novartis, Johnson and Johnson Medical.

Emeel Joined Veriton Pharma in 2011 in the role of Regional Sales Manager before being promoted to be General Manager Middle East and Africa based in Dubai.

 

Unlicensed 'Special' Products

Our heritage of developing tailor-made medications enables Veriton Pharma to provide a range of unlicensed therapy options for those patients whose clinical needs are not met by licensed medications.

Find out more

What people say

“We have ordered certain medicines from Veriton Pharma  for many years and find that you are always there when we need you, a friendly contact...”- Procurement Pharmacist; NHS hospital
“Thank you for putting together a superb educational day for myself and the other epilepsy nurses. We all learned so much that will help patients...”- Sarah. Epilepsy Specialist Nurse, NHS Wales
“Just to say a big thank you for your support with training materials. It was great to have someone on my side trying to sort...”- Clinical Nurse Specialist/Training Lead
“Veriton Pharma truly went that extra mile to ensure a patients emergency medication was supplied at short notice enabling the patient to travel outside the...”- Epilepsy Nurse Specialist, Glasgow
More testimonials

News

    • SERB Announces the Acquisition of Veriton Pharma

                                                                 … Read More

    • SAPHNA Annual Conference 2019: HEALTH FOR ALL CHILDREN

      SAPHNA Annual Conference 2019: 18th June in Manchester We are delighted to be attending the upcoming SAPHNA Annual Conference; HEALTH FOR ALL CHILDREN – School and Public Health Nurses Turning the Tide…. Read More

    • Young Epilepsy online guide for school

      Veriton Pharma is pleased to announce the online publication of the charity Young Epilepsy’s online guide for schools. This comprehensive resource aimed at improving the management and support of children with epilepsy… Read More

    • Young Epilepsy and Veriton Pharma Ltd announce key partnership agreement in support of the charity’s ‘Rules 4 Schools’ campaign

      Young Epilepsy and Veriton Pharma Ltd (Veriton) have announced a key agreement, where the organisations will work in partnership to deliver the ‘Rules 4 Schools” element of the charity’s newly… Read More

About us
  • Company
  • History
  • Leadership Team
  • Testimonials
  • Sponsorship
  • Anti-Bribery Statement
Licensed Products
  • Epistatus®
Unlicensed Products
  • Epilepsy
  • Paediatric Medicine
  • Inborn Errors of Metabolism
  • FAQs
Quality & Service
  • Medical Information & Quality
  • Commercial Team
  • Ordering
Distribution
  • Distribution Footprint
  • Licensing Opportunities
  • Out-licensing Opportunities
© 2017 VERITON PHARMA | Privacy policy | Terms and conditions | another immaculate site
Contact us Linkedin